Karyopharm Therapeutics Inc.KPTINASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
1.48
↓ 100% below average
Average (9y)
391.37
Historical baseline
Range
High:1965.44
Low:1.48
CAGR
-54.2%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 1.48 | -3.6% |
| 2023 | 1.53 | -25.4% |
| 2022 | 2.05 | -9.0% |
| 2021 | 2.25 | -79.0% |
| 2020 | 10.72 | -62.9% |
| 2019 | 28.91 | +69.9% |
| 2018 | 17.02 | -92.6% |
| 2017 | 231.27 | -88.2% |
| 2016 | 1965.44 | +18.9% |
| 2015 | 1652.98 | - |